Home NDC 0121-0868 Nystatin
Product NDC 0121-0868
11-digit product format 001210868
Labeler code 0121
Product ID 0121-0868_7d265612-edc5-42bc-8e58-bae7d7ab7918
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name NYSTATIN
Dosage form SUSPENSION
Route ORAL
Labeler PAI Holdings, LLC dba PAI Pharma
Application ANDA203621
Marketing category ANDA
Marketing start 2020-07-17
Substance NYSTATIN
Active strength 100000 [USP'U]/mL
Pharmacologic classes Polyene Antifungal [EPC], Polyenes [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 11 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A203621-001 NYSTATIN NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A203621-001 AA
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 c2088c7a36db…2026-09-14 22:38:34 2026-08 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 84e616aacf4f…2026-08-18 06:07:40 2026-07 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A203621-001 NYSTATIN 100,000 UNITS/ML SUSPENSION / ORAL AA 2016-01-07 3bdfa0b2c4d7…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 45 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Nystatin
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength NYSTATIN 100000 [USP'U]/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination BDF1O1C72E Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 312055 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0121-0868 NYSTATIN SUSPENSION [PAI HOLDINGS, LLC DBA PAI PHARMA] 8 Current NDC, Legacy NDC, 9 package rows 20240906_28b4e26e-206a-4e8a-abfe-774b780e91c3.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
DailyMed RxNorm Mappings# RxCUI, RxNorm string, TTY table RxCUI RxNorm string TTY DailyMed SPL version 312055 nystatin 100,000 UNT/mL Oral Suspension PSN 28b4e26e-206a-4e8a-abfe-774b780e91c3 8 312055 nystatin 100000 UNT/ML Oral Suspension SCD 28b4e26e-206a-4e8a-abfe-774b780e91c3 8 312055 nystatin 100,000 UNT/ML Oral Suspension SY 28b4e26e-206a-4e8a-abfe-774b780e91c3 8 312055 nystatin 500,000 UNT per 5 ML Oral Suspension SY 28b4e26e-206a-4e8a-abfe-774b780e91c3 8 312055 nystatin 100,000 UNT/mL Oral Suspension PSN d59098da-1395-49fb-9fd6-947bbbeed56f 7 312055 nystatin 100000 UNT/ML Oral Suspension SCD d59098da-1395-49fb-9fd6-947bbbeed56f 7 312055 nystatin 100,000 UNT/ML Oral Suspension SY d59098da-1395-49fb-9fd6-947bbbeed56f 7 312055 nystatin 500,000 UNT per 5 ML Oral Suspension SY d59098da-1395-49fb-9fd6-947bbbeed56f 7 312055 nystatin 100,000 UNT/mL Oral Suspension PSN cc3516cd-985c-489f-b4a1-8477876c5a97 6 312055 nystatin 100000 UNT/ML Oral Suspension SCD cc3516cd-985c-489f-b4a1-8477876c5a97 6 312055 nystatin 100,000 UNT/ML Oral Suspension SY cc3516cd-985c-489f-b4a1-8477876c5a97 6 312055 nystatin 500,000 UNT per 5 ML Oral Suspension SY cc3516cd-985c-489f-b4a1-8477876c5a97 6 312055 nystatin 100,000 UNT/mL Oral Suspension PSN d8c251a6-d4da-4664-bff4-6868541d1178 1 312055 nystatin 100,000 UNT/mL Oral Suspension PSN 1e1b762a-800f-b79c-e063-6294a90a99c9 1 312055 nystatin 100000 UNT/ML Oral Suspension SCD d8c251a6-d4da-4664-bff4-6868541d1178 1 312055 nystatin 100000 UNT/ML Oral Suspension SCD 1e1b762a-800f-b79c-e063-6294a90a99c9 1 312055 nystatin 100,000 UNT/ML Oral Suspension SY 1e1b762a-800f-b79c-e063-6294a90a99c9 1 312055 nystatin 100,000 UNT/ML Oral Suspension SY d8c251a6-d4da-4664-bff4-6868541d1178 1 312055 nystatin 500,000 UNT per 5 ML Oral Suspension SY 1e1b762a-800f-b79c-e063-6294a90a99c9 1 312055 nystatin 500,000 UNT per 5 ML Oral Suspension SY d8c251a6-d4da-4664-bff4-6868541d1178 1
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0121-0868-00 00121086800 10 TRAY in 1 CASE (0121-0868-00) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-0868-05) 10 tray 2020-07-17 0000-00-00 No No Current 0121-0868-02 00121086802 60 mL in 1 BOTTLE, DROPPER (0121-0868-02) 60 ml 2020-07-17 0000-00-00 No No Current 0121-0868-05 00121086805 5 mL in 1 CUP, UNIT-DOSE 5 ml Historical 0121-0868-16 00121086816 473 mL in 1 BOTTLE (0121-0868-16) 473 ml 2020-07-17 0000-00-00 No No Current 0121-0868-40 00121086840 4 TRAY in 1 CASE (0121-0868-40) > 10 CUP, UNIT-DOSE in 1 TRAY > 5 mL in 1 CUP, UNIT-DOSE (0121-0868-05) 4 tray 2020-07-17 0000-00-00 No No Current 0121-0868-50 00121086850 5 TRAY in 1 CASE (0121-0868-50) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-0868-05) 5 tray 2020-07-17 0000-00-00 No No Current